02211 UNI HEALTH
- 0.169
- -0.003-1.74%
UNI HEALTH News
How can the results of major health research be translated into practice? This forum, gathering Medical Institutions, entrepreneurs, investment Institutions, and Universities, is here.
The forum on the transformation of scientific achievements in the big health industry, co-hosted by the Antai College of Economics and Management at Shanghai Jiao Tong University and the Zhongyin Technology Finance College at Shanghai Jiao Tong University, was held at the Shanghai Machinery Valley Industrial Park. Guests from Medical institutions, investment Institutions, and Universities' research institutes discussed the transformation of scientific achievements in the big health industry.
China Pacific Insurance launched the construction of a Retirement Community and Yuan Shen Rehabilitation Hospital project in Guangzhou, with a focus on the South China Greater Bay Area Concept and the Global Strategy in the broad region and health sector.
The Taibao Home · Guangzhou International Retirement Community project launched its Engineering & Construction on December 19. The construction start ceremony for the Taibao Home Guangzhou International Retirement Community and Guangzhou Yuanshen Health Hospital project was held, marking China Pacific Insurance's advancement towards providing integrated solutions for Retirement and health services to a wide range of insurance clients in the South China Greater Bay Area under the framework of the Global Strategy in the large area and health field. This is also an important measure to actively implement the recent guideline issued jointly by the Central Bank and nine other departments regarding financial support for China's Retirement industry and the high-quality development of the Silver economy. It embodies China Pacific Insurance's strategy of regional characteristic development.
Xi'an Global Printing (002799.SZ): Focus on the research and development, production, and services of high-end exquisite packaging and related packaging materials for paper products such as Cosmetic, medical instruments, health products, and fast-moving c
On December 18, Gelonghui reported that Xi'an Global Printing (002799.SZ) stated on its investor interaction platform that the company, as a professional supplier of pharmaceutical packaging, mainly engages in the research and development, production, and sales of pharmaceutical packaging products, while providing customers with integrated packaging solutions including planning, graphic design, structural design, warehousing management, and logistics delivery. At the same time, the company focuses on developing mid-to-high-end exquisite packaging and related packaging materials for medical cosmetic products, medical instruments, health products, and fast-moving consumer goods.
Express News | Maiwei Bio plans to jointly invest with the Chongqing High-tech Zone Management Committee and the Big Health Fund to build the "Maiwei Bio Bone Health Innovative Drugs Project."
Tianjin Ringpu Bio-Technology (300119.SZ) plans to spend 0.104 billion yuan to acquire a 56.31% stake in Zhongrui Supply Chain, enhancing the layout of the pet health sector.
Tianjin Ringpu Bio-Technology (300119.SZ) announced that the company intends to acquire Ruipai for 0.104 billion yuan using its own funds or self-raised funds...
Inner Mongolia Yili Industrial Group (600887.SH) plans to participate in the Anhui Jianling Seed Fund, focusing on high-tech innovation and entrepreneurship in the health and wellness field.
Inner Mongolia Yili Industrial Group (600887.SH) announced that its wholly-owned limited partnership Zhuhai Jianling Private Equity Fund Management...
Express News | Wanbangde Pharmaceutical Holding Group plans to establish a wholly-owned subsidiary to promote the strategic development of the company's pharmaceutical health industry.
VOLCANO SPRING (01715.HK) plans to establish a joint venture to explore the big health field.
On December 12, Gelonghui reported that VOLCANO SPRING (01715.HK) announced an agreement with Yougu Health Technology to establish a joint venture in China on December 12, 2024, aimed at exploring the big health sector. According to the joint venture agreement, the registered capital will be 1 million yuan. The company and Yougu Health Technology will contribute registered capital of 0.51 million yuan and 0.49 million yuan to the joint venture company respectively. After its establishment, the joint venture company will be 51% owned by the company, and its financial performance will be incorporated into the group's consolidated financial statements.
Awarded the "Annual Outstanding Health Company", hepalink (002399.SZ/9989.HK) interprets value through steady growth.
In today's society, where population aging is becoming increasingly severe, health has become a focal point of great concern. With the enhancement of public health awareness and continuous advancements in technology, a company's innovation capabilities and market performance have become key indicators for measuring its standing in the industry. The global health industry is facing unprecedented development opportunities and challenges. In this context, the 9th "Gelonghui Global Investment Carnival 2025" recently grandly opened, and hepalink, as the leader of the heparin industry chain, won the "Annual Excellence in Global Health Enterprise" award. The "Annual Excellence in Global Health Enterprise" award considers multiple aspects such as product production, service provision, and information dissemination.
A model for the integration of precision medical and technology, bgi genomics (300676.SZ) received the "Annual Outstanding Big Health Enterprise" award.
Health is not only the foundation of individual quality of life, but also an important factor for social stability and economic development. Today, with the improvement of living standards and the enhancement of health awareness, people's attention to health issues has reached unprecedented heights. In the face of this global trend, many companies are entering the big health industry, committed to improving the quality and efficiency of medical services through technological innovation to meet the growing health needs of people. Against this background, bgi genomics (300676.SZ) has demonstrated outstanding performance in the deep integration of technological innovation and precision medical.
Futu Morning Report | Optimistic sentiment is rising again! The three major U.S. stock indexes have all reached new highs; bullish financial reports for AI applications and chip stocks are driving an investment boom, with marvell technology soaring over 2
Powell: The economy is stronger than expected, the Federal Reserve can lower interest rates "more cautiously", and the Trump administration cannot appoint a shadow Fed chair; Trump nominates crypto-friendly Paul Atkins to be the SEC chair.
U.S. stocks closed: all three major indexes hit new highs as Trump ignited a cryptos frenzy, while AI applications and the chip sector showed more bullish earnings reports.
1. Jerome Powell's wording was "just right", and the Dow Jones Industrial Average closed above 45,000 points for the first time in history; 2. AI applications and chip sectors once again showed bullish financial report news; 3. The CEO of the largest health insurance company in the usa was assassinated on the street; 4. Trump nominated an SEC chairman with a pro-cryptos stance.
Asia Vets (NASDAQ: AIFU): Reshaping AI insurance and the big health industry, is the future promising?
Hong Kong, November 29, 2024 /PRNewswire/ -- Asia Vets Future Limited (NASDAQ: AIFU), a leading company focusing on insurance agency and claims services. Recently, the company has been gradually promoting its transformation towards intelligence and diversification, aiming to seize the potential growth opportunities in AI insurance and the big health sector. The restructuring of its high-quality assets and strategic cooperation with Bohme Group (NASDAQ: BGM) are expected to create a second curve of future performance growth for the company. 1. Restructure high-quality assets to create a smarter future, AIFU recently restructured its core assets, involving an amount of
Express News | Yunnan Baiyao Group intends to invest 5 billion yuan to establish the Yunnan Traditional Chinese Medicine Health Innovation Fund jointly with professional investment institutions.
Jin Huo 30th Anniversary Series Event | Longde Health Industry Park Grand Opening, Jin Huo Writes a New Chapter in the Health Industry.
On November 26, 2024, the grand opening ceremony of the Kingworld-Longde Health Industry Park was held in Shenzhen, marking the beginning of the 30th anniversary celebration of Kingworld Group. On the same day, the new product 'Foci-Kingworld Angong Niuhuang Pills' jointly launched by Foci and Kingworld was also listed and debuted, a series of milestone celebration activities indicating Kingworld Pharmaceuticals' confidence and determination to continue to write a new chapter in the medical and health industry. After four years of hard work, the Longde Park creates a new business card for Longgang Health. The Longde Health Industry Park is developed by Kingworld Pharmaceuticals (01110.HK) in accordance with the national health industry development strategy combined with the industrial development plans of Shenzhen and Longgang District.
Yixintang Pharmaceutical (002727.SZ): Yixintang in Sichuan plans to invest 0.368 billion yuan to construct a large health smart medicine base logistics center project.
On November 26, Yixintang Pharmaceutical (002727.SZ) announced that, according to the company's global strategy and business positioning, in order to improve the logistics distribution capabilities in Sichuan province and meet future development needs, the company has approved its wholly-owned subsidiary, Sichuan Yixintang Pharmaceutical Co., Ltd. (hereinafter referred to as "Sichuan Yixintang"), to invest 0.368 billion yuan in Chengdu, Sichuan province to construct a large health smart medical logistics center project. The construction of the new logistics center is intended to meet the business development needs of the company in the Sichuan-Chongqing region.
Express News | Sichuan Kelun Pharmaceutical established a big health industry company in Zhejiang with a registered capital of 20 million yuan.
Universal Health International Unit Buys Stake in Hollow Capsule Manufacturer
Uni Health (02211.HK) sells capsule production business at a price of 43 million RMB.
Uni Health (02211.HK) announced the complete sale of capsule production business to an independent third party - 43.78% equity of Jilin Jintiandi Uni Health Group, for a cash consideration of RMB 43 million. The net proceeds will be used for general operating funds.
Uni health (02211.HK) intends to sell a 43.78% stake in Jilin Jintian Uni Health Group for 43 million yuan.
On November 19, 2023, uni health (02211.HK) announced that on November 19, 2024, the seller (Heilongjiang Jintian Aixin Pharmaceutical Distribution Co., Ltd.) (an indirectly wholly-owned subsidiary of the company) entered into an equity transfer agreement with the buyer (Huang Yanling), according to which the seller conditionally agreed to sell, and the buyer conditionally agreed to acquire 43.78% of the equity of the target company Jilin Jintian Uni Health Group Capsule Co., Ltd., for a consideration of 43 million yuan, but it is subject to the terms of the equity transfer agreement. After the completion of the sale, the company will no longer hold any equity in the target company.
No Data